Holen Sie sich die Stockscreener-App
1.40
4.44%
-0.065
Handel nachbörslich:
1.39
-0.01
-0.71%
Schlusskurs vom Vortag:
$1.465
Offen:
$1.45
24-Stunden-Volumen:
7,484
Relative Volume:
0.07
Marktkapitalisierung:
$2.03M
Einnahmen:
$2,000
Nettoeinkommen (Verlust:
$-12.72M
KGV:
-0.0195
EPS:
-71.8121
Netto-Cashflow:
$-3.91M
1W Leistung:
-0.71%
1M Leistung:
-23.91%
6M Leistung:
-69.23%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.37
$1.45
1-Wochen-Bereich:
$1.1401
$1.66
52-Wochen-Spanne:
$1.1401
$23.80
Nexentis Technologies Inc Stock (NXTS) Company Profile
Firmenname
Nexentis Technologies Inc
Sektor
Branche
Telefon
972544561349
Adresse
156 FIFTH AVENUE 10TH FLOOR, NEW YORK
Compare NXTS vs CTVA, NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXTS
Nexentis Technologies Inc
|
1.40 | 2.14M | 2,000 | -12.72M | -3.91M | -71.81 |
CTVA
Corteva Inc
|
77.87 | 52.39B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
71.18 | 34.47B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
115.71 | 17.35B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
22.42 | 7.31B | 12.43B | 70.90M | -489.30M | 0.1275 |
ICL
Icl Group Ltd
|
5.17 | 6.63B | 7.41B | 314.00M | 220.88M | 0.202 |
Nexentis Technologies Inc Aktie (NXTS) Neueste Nachrichten
Nexentis Technologies Inc. (NXTS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nexentis Technologies Inc. (NXTS) stock price, news, quote and history - Yahoo Finance UK
Nexentis appoints computational chemistry expert to advisory board - Investing.com
Nexentis appoints computational chemistry expert to advisory board By Investing.com - Investing.com Nigeria
Nexentis Technologies Announces Appointment of Prof. Dan T. Major to MitoCareX Scientific Advisory Board - Quiver Quantitative
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board - GlobeNewswire
Nexentis subsidiary evaluates ways for obtaining proteins in in-vitro research - TipRanks
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery - The Manila Times
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities - GlobeNewswire
Nexentis Technologies Inc. (NASDAQ: NXTS) Share Price, NXTS Stock News, NXTS Share Price & Updates - kalkine.com.au
Top Nexentis Technologies (NXTS) Competitors 2026 - MarketBeat
NXTS Q2 2025 Earnings: Reported Per-Share Loss of $0.18 as Stock Edges Up 1.2%Return On Equity - dars.gov.et
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis Faces Nasdaq Delisting Over Equity Shortfall - Minichart
Nexentis Technologies Faces Nasdaq Compliance and Delisting Risk - TipRanks
Nexentis Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NXTS - Finviz
Nexentis Technologies Inc. (NXTS) Rises 5.98% to $1.95, Approaching Key Resistance at $2.05Hedge Fund Favorites - Vinanet
Nexentis Technologies (NXTS) flags going concern after $17.7M loss and $6.3M impairment - Stock Titan
Nexentis Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexentis Technologies (NASDAQ: NXTS) changes auditors after prior going concern note - Stock Titan
Nexentis Technologies (NXTS) Gains 4% as Bullish Momentum Builds Toward Key $2.03 ResistanceIchimoku Entry - dars.gov.et
NXTS Q2 2025 Earnings: Loss of $0.18 Per Share Reported as Stock Climbs 10.32%Analyst Earnings Estimate - vinanet.vn
NXTS Q2 2025 Earnings: Reported Loss of -$0.18 Per Share, Yet Shares Jump 10.32%Profit Margin Analysis - careplusvn.com
Nexentis subsidiary selects candidate for drug discovery program By Investing.com - Investing.com Canada
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign - globenewswire.com
Nexentis Technologies Inc. (NXTS) Q2 2025 Earnings: Loss and Stock Decline Reflect Ongoing Challenges - dars.gov.et
Nexentis Technologies Inc. Revenue Breakdown – NASDAQ:NXTS - TradingView
Nexentis Technologies (NXTS) Drops 7%: Key Support Level in FocusElliott Wave Entry - dars.gov.et
NXTS Q2 2025 Earnings: Wider-than-expected loss drives shares down 7.86%Earnings Momentum Score - dars.gov.et
Nexentis Technologies Inc. SEC Filing (Jul 20, 2026) - Stock Titan
NXTS Q2 2025 Earnings: Reported Loss of $0.18 per Share Amid Market SelloffAnalyst Drop Coverage - dars.gov.et
Nexentis Technologies soars 156% before falling 46% after hours — here’s why NXTS stock is trending - MSN
Nexentis Technologies Inc. SEC Filing (Jul 16, 2026) - Stock Titan
Eun Young Lee holds 3.23% of Nexentis Technologies Inc. (NXTS) - Stock Titan
NXTS Q2 2025 Earnings: Wider-Than-Expected Loss Sends Shares LowerMargin Compression Risk - vinanet.vn
Nexentis Technologies files prospectus for 2.573M shares - scanx.trade
Nexentis Technologies (NASDAQ: NXTS) refreshes $100M shelf and details MitoCareX deal - Stock Titan
Nexentis Technologies registers to sell 2.57M shares of common stock for holders - TipRanks
Nexentis Technologies (NASDAQ: NXTS) registers 2.57M warrant shares for resale - Stock Titan
Nexentis Technologies Q2 2025 Earnings: Loss of -$0.18 Per Share Sends Stock Down 14.56%Energy Earnings Report - dars.gov.et
Nexentis Technologies (NXTS) Slides 4.5% as Selling Pressure Tests Key Support at $3.46Double EMA - dars.gov.et
NXTS Q2 2025 Earnings: Net Loss of $0.18 Per Share as Stock Slips 3.6%Earnings Quality Score - dars.gov.et
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative - The Manila Times
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter - GlobeNewswire
Nexentis Technologies Shares Gain 10% on Partial Monetisation of German Solar ProjectPreliminary Results - Vinanet
Nexentis stock jumps on solar project monetization deal - Investing.com
Nexentis Announces Monetization of Part of It - Moomoo
NXTS Q2 2025 Earnings: A Disappointing Quarter as Losses Widen and Shares TumbleEarnings Yield Spread - dars.gov.et
Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS) - Yahoo Finance
Nexentis Technologies announces monetization of Melz solar investment - TipRanks
Finanzdaten der Nexentis Technologies Inc-Aktie (NXTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.25%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):